Group One Trading’s Lunai Bioworks LNAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1 Sell
1
-543
-100% -$1.3K ﹤0.01% 7443
2026
Q2
$1.78K Sell
544
-1
-0.2% -$3 ﹤0.01% 7061
2026
Q1
$1.78K Buy
545
+312
+134% +$1.55K ﹤0.01% 7085
2025
Q4
$1.64K Buy
233
+13
+6% +$116 ﹤0.01% 7613
2025
Q3
$229 Buy
220
+219
+21,900% +$4.22K ﹤0.01% 8206
2025
Q2
$29 Buy
+1
New +$28 ﹤0.01% 7814
2023
Q3
– Hold
0
– – – 8176
2023
Q2
– Sell
-1
Closed -$77 – 7574
2023
Q1
$63 Buy
+1
New +$88 ﹤0.01% 7057
2022
Q3
– Sell
-39
Closed -$7.11K – 8115
2022
Q2
$6K Buy
+39
New +$17.8K ﹤0.01% 7021
2022
Q1
– Sell
-24
Closed -$12.8K – 8577
2021
Q4
$14K Buy
24
+7
+41% +$5.08K ﹤0.01% 7187
2021
Q3
$9K Buy
+17
New +$8.3K ﹤0.01% 7559

Other funds holding LNAI

Group One Trading's LNAI Position: Q3 2026 in Review

Group One Trading reduced its Lunai Bioworks (LNAI) stake by 100% in Q3 2026, selling an estimated $1.3K and leaving 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #7443.

Group One Trading first reported a position in LNAI in Q3 2021 and has held it in 10 quarters since. The position peaked at $14K in Q4 2021. 15 funds tracked by Wall St. Rank hold LNAI as of Q3 2026.

  • Group One Trading held 1 share of Lunai Bioworks worth $1 as of Q3 2026.
  • Group One Trading sold 543 Lunai Bioworks shares in Q3 2026, an estimated $1.3K.
  • Lunai Bioworks made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7443 holding.
  • Group One Trading first reported a position in Lunai Bioworks in Q3 2021 and has held it in 10 quarters since.
  • Group One Trading's Lunai Bioworks position peaked at $14K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.